| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |